IL-15 promotes the survival of naive and memory phenotype CD8+ T cells

被引:285
作者
Berard, M
Brandt, K
Paus, SB
Tough, DF [1 ]
机构
[1] Edward Jenner Inst Vaccine Res, Newbury RG20 7NN, Berks, England
[2] Res Ctr Borstel, Dept Immunol & Cell Biol, Borstel, Germany
关键词
D O I
10.4049/jimmunol.170.10.5018
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-15 stimulates the proliferation of memory phenotype CD44(high)CD8(+) T cells and is thought to play a key role in regulating the turnover of these cells in vivo. We have investigated whether IL-15 also has the capacity to affect the life span of naive phenotype (CD44(low)) CD8(+) T cells. We report that IL-15 promotes the survival of both CD44(low) and CD44(high) CD8(+) T cells, doing so at much lower concentrations than required to induce proliferation of CD44(high) cells. Rescue from apoptosis was associated with the up-regulation of Bcl-2 in both cell types, whereas elevated expression of Bcl-X-L was observed among CD44 high but not CD44(low) CD8(+) cells. An investigation into the role of IL-15R subunits in mediating the effects of IL-15 revealed distinct contributions of the alpha- and beta- and gamma-chains. Most strikingly, IL-15Ralpha was not essential for either induction of proliferation or promotion of survival by IL-15, but did greatly enhance the sensitivity of cells to low concentrations of IL-15. By contrast, the beta- and gamma-chains of the IL-15R were absolutely required for the proliferative and pro-survival effects of IL-15, although it was not necessary for CD44 high CD8(+) cells to express higher levels of IL-15Rbeta than CD44(low) cells to proliferate in response to IL-15. These results show that IL-15 has multiple effects on CD8(+) T cells and possesses the potential to regulate the life span of naive as well as memory CD8(+) T cells.
引用
收藏
页码:5018 / 5026
页数:9
相关论文
共 64 条
  • [31] POSITIVE AND NEGATIVE SELECTION IN TRANSGENIC MICE EXPRESSING A T-CELL RECEPTOR-SPECIFIC FOR INFLUENZA NUCLEOPROTEIN AND ENDOGENOUS SUPERANTIGEN
    MAMALAKI, C
    ELLIOTT, J
    NORTON, T
    YANNOUTSOS, N
    TOWNSEND, AR
    CHANDLER, P
    SIMPSON, E
    KIOUSSIS, D
    [J]. DEVELOPMENTAL IMMUNOLOGY, 1993, 3 (03): : 159 - 174
  • [32] IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice
    Marks-Konczalik, J
    Dubois, S
    Losi, JM
    Sabzevari, H
    Yamada, N
    Feigenbaum, L
    Waldmann, TA
    Tagaya, Y
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (21) : 11445 - 11450
  • [33] The permeability transition pore complex:: A target for apoptosis regulation by caspases and Bcl-2-related proteins
    Marzo, I
    Brenner, C
    Zamzami, N
    Susin, SA
    Beutner, G
    Brdiczka, D
    Rémy, R
    Xie, ZH
    Reed, JC
    Kroemer, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (08) : 1261 - 1271
  • [34] Interleukin-15 prevents mouse mast cell apoptosis through STAT6-mediated Bcl-xL expression
    Masuda, A
    Matsuguchi, T
    Yamaki, K
    Hayakawa, T
    Yoshikai, Y
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) : 26107 - 26113
  • [35] IL-15 is expressed by dendritic cells in response to type IIFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation
    Mattei, F
    Schiavoni, G
    Belardelli, F
    Tough, DF
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (03) : 1179 - 1187
  • [36] Meazza R, 1998, INT J CANCER, V78, P189, DOI 10.1002/(SICI)1097-0215(19981005)78:2<189::AID-IJC12>3.0.CO
  • [37] 2-6
  • [38] LIFE-SPAN OF HUMAN LYMPHOCYTE SUBSETS DEFINED BY CD45 ISOFORMS
    MICHIE, CA
    MCLEAN, A
    ALCOCK, C
    BEVERLEY, PCL
    [J]. NATURE, 1992, 360 (6401) : 264 - 265
  • [39] Persistence of memory CD8 T cells in MHC class I-deficient mice
    Murali-Krishna, K
    Lau, LL
    Sambhara, S
    Lemonnier, F
    Altman, J
    Ahmed, R
    [J]. SCIENCE, 1999, 286 (5443) : 1377 - 1381
  • [40] Enhanced survival and potent expansion of the natural killer cell population of HIV-infected individuals by exogenous interleukin-15
    Naora, H
    Gougeon, ML
    [J]. IMMUNOLOGY LETTERS, 1999, 68 (2-3) : 359 - 367